Viewing Study NCT05460195


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-02-07 @ 6:21 AM
Study NCT ID: NCT05460195
Status: UNKNOWN
Last Update Posted: 2022-07-15
First Post: 2022-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation
Sponsor: Shanghai Chest Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
None Minimal Residual Disease View
None Immunotherapy View
None Anti-angiogenesis View
Keywords: